Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.900
-0.080 (-4.04%)
At close: Dec 20, 2024, 9:51 AM
1.950
+0.050 (2.63%)
After-hours: Dec 20, 2024, 4:00 PM EST
Armata Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 5.47 | 4.53 | 5.51 | 4.47 | 0.82 | - | |
| Revenue Growth (YoY) | 34.92% | -17.77% | 23.11% | 443.62% | - | - | |
| Cost of Revenue | 33.52 | 33.77 | 35.02 | 20.02 | 14.44 | 8.32 | |
| Gross Profit | -28.05 | -29.24 | -29.51 | -15.54 | -13.62 | -8.32 | |
| Selling, General & Admin | 13.04 | 11.65 | 7.44 | 8.28 | 7.97 | 9.67 | |
| Research & Development | 0.38 | - | - | - | - | - | |
| Operating Expenses | 13.42 | 11.65 | 7.44 | 8.28 | 7.97 | 9.67 | |
| Operating Income | -41.48 | -40.89 | -36.95 | -23.82 | -21.59 | -17.99 | |
| Interest Expense | -8.91 | -2.63 | - | -0.06 | -0.63 | -0.93 | |
| Interest & Investment Income | 0.64 | 0.18 | 0.03 | 0.01 | 0.03 | 0.1 | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.01 | 1.11 | |
| EBT Excluding Unusual Items | -49.75 | -43.34 | -36.92 | -23.88 | -22.18 | -17.72 | |
| Merger & Restructuring Charges | - | - | - | - | - | -1.1 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.66 | |
| Other Unusual Items | 8.39 | -25.71 | - | 0.73 | - | - | |
| Pretax Income | -41.36 | -69.05 | -36.92 | -23.16 | -22.18 | -19.48 | |
| Net Income | -41.36 | -69.05 | -36.92 | -23.16 | -22.18 | -19.48 | |
| Net Income to Common | -41.36 | -69.05 | -36.92 | -23.16 | -22.18 | -19.48 | |
| Shares Outstanding (Basic) | 36 | 36 | 34 | 24 | 16 | 8 | |
| Shares Outstanding (Diluted) | 36 | 36 | 34 | 24 | 16 | 8 | |
| Shares Change (YoY) | 0.21% | 5.19% | 42.27% | 46.84% | 104.93% | 72.15% | |
| EPS (Basic) | -1.14 | -1.91 | -1.08 | -0.96 | -1.35 | -2.49 | |
| EPS (Diluted) | -1.14 | -1.91 | -1.08 | -0.96 | -1.35 | -2.55 | |
| Free Cash Flow | -42.09 | -55.57 | -34.69 | -24.88 | -19.09 | -15.81 | |
| Free Cash Flow Per Share | -1.16 | -1.54 | -1.01 | -1.03 | -1.16 | -1.97 | |
| Operating Margin | -758.66% | -902.85% | -670.77% | -532.45% | -2622.96% | - | |
| Profit Margin | -756.59% | -1524.51% | -670.24% | -517.55% | -2695.14% | - | |
| Free Cash Flow Margin | -769.82% | -1226.92% | -629.85% | -556.08% | -2320.05% | - | |
| EBITDA | -40.24 | -39.92 | -36.05 | -22.65 | -20.47 | -16.64 | |
| D&A For EBITDA | 1.24 | 0.97 | 0.89 | 1.17 | 1.11 | 1.35 | |
| EBIT | -41.48 | -40.89 | -36.95 | -23.82 | -21.59 | -17.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.